Opaleye Management’s Cytokinetics CYTK Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-75,300	Closed	-$3.98M	–	44
2024 Q3	$3.98M	Sell	75,300 -123,200	-62%	-$6.5M	0.66%	27
2024 Q2	$10.8M	Buy	+198,500	New	+$10.8M	2.46%	8
2023 Q3	–	Sell	-130,000	Closed	-$4.24M	–	44
2023 Q2	$4.24M	Sell	130,000 -77,500	-37%	-$2.53M	1.01%	26
2023 Q1	$7.3M	Sell	207,500 -42,500	-17%	-$1.5M	2.19%	12
2022 Q4	$11.5M	Sell	250,000 -13,000	-5%	-$596K	3.98%	6
2022 Q3	$12.7M	Sell	263,000 -39,500	-13%	-$1.91M	5.26%	6
2022 Q2	$11.9M	Sell	302,500 -104,000	-26%	-$4.09M	5.36%	5
2022 Q1	$15M	Sell	406,500 -173,500	-30%	-$6.39M	4.65%	6
2021 Q4	$26.4M	Hold	580,000	–	–	5.61%	6
2021 Q3	$20.7M	Hold	580,000	–	–	3.87%	8
2021 Q2	$11.5M	Hold	580,000	–	–	1.91%	16
2021 Q1	$13.5M	Sell	580,000 -2,800	-0.5%	-$65.1K	1.98%	15
2020 Q4	$12.1M	Buy	582,800 +374,000	+179%	+$7.77M	1.58%	19
2020 Q3	$4.52M	Sell	208,800 -94,250	-31%	-$2.04M	0.88%	35
2020 Q2	$7.14M	Buy	+303,050	New	+$7.14M	1.44%	25
2019 Q4	–	Sell	-650,000	Closed	-$7.4M	–	49
2019 Q3	$7.4M	Sell	650,000 -250,000	-28%	-$2.85M	2.67%	16
2019 Q2	$10.1M	Buy	900,000 +50,000	+6%	+$563K	3.09%	13
2019 Q1	$6.88M	Buy	+850,000	New	+$6.88M	1.9%	23